Zeposia यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

zeposia

bristol-myers squibb pharma eeig - ozanimod stutt og long-term - multiple sclerosis, relapsing-remitting; colitis, ulcerative - Ónæmisbælandi lyf - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Duta Tamsaxiro Hart hylki 0,5/0,4 mg आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

duta tamsaxiro hart hylki 0,5/0,4 mg

medical valley invest ab - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg

Duodart Hart hylki 0,5/0,4 mg आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

duodart hart hylki 0,5/0,4 mg

glaxosmithkline pharma a/s - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg

Dutaprostam Hart hylki 0,5/0,4 mg आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

dutaprostam hart hylki 0,5/0,4 mg

zentiva k.s.* - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg